Austin Scott
Austin Scott (R-GA) sold $1K-$15K of $GEV (GE Vernova Inc. Common Stock) on Jun 16, 2025, part of 17 transactions in this filing.
HillSignal flagged 2 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Companies in this filing · 7
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Suspicious Timing Detected
2 flagsRep. Austin Scott sold $1,001 - $15,000 in $GEHC on 2025-03-27, 70 days before the 'Supporting Healthy Moms and Babies Act' (HR3762) was introduced. This bill mandates comprehensive maternal care, which could impact healthcare providers.
Rep. Austin Scott sold $1,001 - $15,000 in $GE (GE Aerospace Common Stock) on 2025-06-16, 94 days before the 'Fight Illicit Pill Presses Act' (S2870) was introduced. This bill expands the definition of 'regulated persons' under the Controlled Substances Act, potentially affecting industrial equipment manufacturers.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| SELL | $GEV | GE Vernova Inc. Common Stock | $1K-$15K | $487.88 | $1,102.51 | +126.0% | Jun 16, 2025 |
| SELL | $GE | GE Aerospace Common Stock | $1K-$15K | $236.54 | $373.71 | +58.0% | May 23, 2025 |
| SELL | $GEV | GE Vernova Inc. Common Stock | $1K-$15K | $487.88 | $1,102.51 | +126.0% | May 23, 2025 |
| SELL | $GEV | GE Vernova Inc. Common Stock | $1K-$15K | $487.88 | $1,102.51 | +126.0% | May 14, 2025 |
| SELL | $GE | GE Aerospace Common Stock | $1K-$15K | $236.54 | $373.71 | +58.0% | Mar 4, 2025 |
| SELL | $GE | GE Aerospace Common Stock | $1K-$15K | $236.54 | $373.71 | +58.0% | Jan 13, 2025 |
| SELL | $GEV | GE Vernova Inc. Common Stock | $1K-$15K | $487.88 | $1,102.51 | +126.0% | Oct 2, 2024 |
| SELL | $BLDP | Ballard Power Systems, Inc. - Common Shares | $1K-$15K | $2.28 | $3.73 | +63.6% | Jul 31, 2024 |
| SELL | $PLUG | Plug Power, Inc. - Common Stock | $1K-$15K | $2.47 | $2.59 | +4.9% | Jul 31, 2024 |
| SELL | $KPLT | Katapult Holdings, Inc. - Common Stock | $1K-$15K | $20.80 | $6.81 | -67.3% | Jul 31, 2024 |
Connected Legislative Activity
7 signalsThese bills and contracts share tickers or sectors with this filing's trades.
A bill to authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.
S. 3103, introduced November 2025, authorizes the President to extend normal trade relations to nearly all countries except Belarus, Cuba, and North Korea. This early-stage bill is stalled in the Senate Finance Committee with no further actions reported. Real market data shows $WMT at $128.01, $TGT at $127.87, and $AAPL at $270.17 as of 2026-04-30, with no discernible price reaction to this procedural bill.
STOP China Act
The STOP China Act (HR4361) is an early-stage bill restricting federal funds for vehicles from Chinese entities. With only 2 cosponsors and referral to committee, this is a low-probability legislative event with no near-term market impact. Real market data shows no correlation — OSK up 3.82% in 7 days, GM down 0.45%, Ford down 4.93% — driven by broader auto sector dynamics, not this bill.
CREATE JOBS Act
The CREATE JOBS Act (S.2056) proposes permanently reinstating 100% bonus depreciation for all U.S. businesses, a proven tax incentive reducing the after-tax cost of capital equipment by 21% in year one. At current market prices, capital-intensive companies like CAT ($810.05), DE ($560.02), FDX ($388.59), and AMZN ($263.04) have already shown strong 30-day momentum (CAT +21.37%, FDX +13.7%, AMZN +30.9%), reflecting broader economic expectations this tax policy reinforces. The bill is in early committee stage with legislative risk high, but identical House companion HR3967 improves odds of eventual enactment.
Supporting Healthy Moms and Babies Act
The 'Supporting Healthy Moms and Babies Act' (HR3762) is an early-stage bill that would mandate comprehensive maternity/newborn care coverage without cost-sharing under ACA plans. With 28 cosponsors, a companion bill in the Senate, and referral to three committees, legislative progress is early but has nominal bipartisan support. Insurers UNH and CI face increased medical costs, while diagnostic labs LH and DGX benefit from higher utilization. No dollar amount is authorized or appropriated.
Fight Illicit Pill Presses Act
The Fight Illicit Pill Presses Act (S. 2870) is an early-stage, non-funding bill that expands DEA recordkeeping rules to makers of pill press equipment. With no procurement, subsidy, or prohibition, market impact is negligible. Illinois Tool Works ($ITW), the only publicly traded company plausibly in this manufacturing niche, faces no material financial effect.
To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.
HR5917 is an early-stage procedural bill authorizing the President to extend normal trade relations to most countries by waiving the Jackson-Vanik amendment. It authorizes no funding and changes no current tariff levels. Real market data shows $WMT at $130.81 near its 52-week high, with a 30-day gain of 5.25%, and $AAPL up 8.8% in 30 days—indicating that favorable trade expectations are already priced in. The bill faces a long legislative path with no near-term market impact.
SEPSIS Act
The SEPSIS Act (S.1929) is an early-stage authorization bill that would create federal programs for sepsis research, education, and data collection. It authorizes but does not appropriate funding, and with only 6 cosponsors and referral to committee in June 2025, passage remains uncertain. Real market data shows all four diagnostic/lab stocks have declined 1-6% in the past week and 2-10% over 30 days, reflecting broader market pressure on healthcare despite the legislative catalyst.
Other Filings by Austin Scott
Free — no credit card
Get the next Scott trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.